Inhibition by 6-aminothymine of the degradation of nucleosides (5-iododeoxyuridine, thymidine) and pyrimidine bases (5-iodouracil, uracil and 5-fluorouracil) in vivo.
D000588:Amines / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000378:metabolism / Q000494:pharmacology*; D001853:Bone Marrow / Q000378:metabolism; D002845:Chromatography; D004247:DNA / Q000378:metabolism; D005472:Fluorouracil / Q000378:metabolism* / Q000633:toxicity; D007065:Idoxuridine / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000378:metabolism; D007457:Iodine Radioisotopes; D008297:Male; D051379:Mice; D009705:Nucleosides / Q000378:metabolism*; D010430:Pentosyltransferases / Q000037:antagonists & inhibitors*; D011817:Rabbits; D013154:Spleen / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism*; D013941:Thymine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology* / Q000031:analogs & derivatives; D013950:Thymus Gland / Q000378:metabolism; D014498:Uracil / Q000031:analogs & derivatives / Q000378:metabolism*
D000588:Amines; D000963:Antimetabolites; D007457:Iodine Radioisotopes; D009705:Nucleosides; C006562:6-aminothymine; D014498:Uracil; D004247:DNA; D010430:Pentosyltransferases; D007065:Idoxuridine; D013941:Thymine; D005472:Fluorouracil; D013936:Thymidine